Hospira Inc.: Infant 25% DEXTROSE Injection, USP, 2.5 g (250 mg/mL), 10 mL Unit
Recall reason: Presence of Particulate Matter: human hair found within an internal sample syringe.. Recalled by Hospira Inc.. Distribution: Nationwide in the USA and Puerto Rico. Classification (Class I — serious health hazard). Affected lots/NDC/dates: Lot 58382EV*, Exp 1OCT 2017, *lot may be followed by 01 or 02. Return the recalled medication to the pharmacy where you purchased it for a full refund of the purchase price.
📬 Get email alerts for new Product Recalls & Refunds
Free — we'll email you when new matching opportunities appear. No spam, unsubscribe anytime.
New here? Here's how Reward Opportunity works:
🔔 More Product Recalls & Refunds
Product recalls offering refunds, replacements, or repairs to consumers who purchased the item.
Browse all product recalls & refunds →Not just this one — find everything you qualify for
Our AI scans 8,000+ bounties, settlements, grants, recalls, and paid studies against your profile to rank what you can actually claim.
Get My Free Match Report